Israel Englander Exact Sciences Corp Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Exact Sciences Corp stock. As of the latest transaction made, Millennium Management LLC holds 11,900 shares of EXAS stock, worth $627,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,900

Previous 30,000 60.33%

Holding current value

$627,130

Previous $1.27 Million 36.07%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $23.9 Million - $39.9 Million	563,929 Added 83.56%	1,238,785 $84.3 Million
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $93.9 Million - $169 Million	-2,271,667 Reduced 77.1%	674,856 $28.5 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $153 Million - $201 Million	2,721,096 Added 1207.09%	2,946,523 $203 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $2.75 Million - $3.52 Million	-46,514 Reduced 17.1%	225,427 $16.7 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $15.8 Million - $24 Million	-252,478 Reduced 48.14%	271,941 $25.5 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $22 Million - $33 Million	466,563 Added 806.42%	524,419 $35.6 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $4.33 Million - $7.58 Million	-142,661 Reduced 71.15%	57,856 $2.86 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $6.41 Million - $9.9 Million	200,517 New	200,517 $6.52 Million
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $143,365 - $306,901	-4,026 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $6.45 Million - $9.25 Million	-112,066 Reduced 96.53%	4,026 $281,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $7.79 Million - $10.8 Million	107,397 Added 1235.16%	116,092 $9.04 Million
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $3.79 Million - $5.2 Million	-41,946 Reduced 82.83%	8,695 $830,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $22.1 Million - $32.8 Million	-235,640 Reduced 82.31%	50,641 $6.3 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $20.1 Million - $26.8 Million	-172,666 Reduced 37.62%	286,281 $37.7 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $44.4 Million - $63.3 Million	-445,488 Reduced 49.26%	458,947 $60.8 Million
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $19.7 Million - $27.5 Million	270,070 Added 42.57%	904,435 $92.2 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $30.4 Million - $50.6 Million	546,028 Added 618.12%	634,365 $55.2 Million
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $2.85 Million - $7.86 Million	-75,304 Reduced 46.02%	88,337 $5.12 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $9.2 Million - $11.8 Million	-118,438 Reduced 41.99%	163,641 $15.1 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $24.6 Million - $33.4 Million	272,562 Added 2863.95%	282,079 $25.5 Million
Q2 2019 Aug 15, 2019	SELL	$89.51 - $118.04 $4.79 Million - $6.31 Million	-53,483 Reduced 84.89%	9,517 $1.12 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $32.8 Million - $43.2 Million	-366,248 Reduced 85.32%	63,000 $8.02 Million
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $4.08 Million - $6.36 Million	-65,861 Reduced 13.3%	429,248 $37.2 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $1.68 Million - $2.48 Million	-30,024 Reduced 5.72%	495,109 $31.2 Million
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $20 Million - $33.4 Million	-413,963 Reduced 44.08%	525,133 $41.4 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $35.5 Million - $65.7 Million	939,096 New	939,096 $56.1 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $1.79 Million - $2.33 Million	-38,425 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $1.42 Million - $1.81 Million	38,425	38,425 $1.81 Million

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.33B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account